mirtazapine has been researched along with Bewilderment in 2 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lim, SY | 1 |
| Bodagh, N | 1 |
| Scott, G | 1 |
| Hill, NE | 1 |
| Gerritsen, AW | 1 |
2 other studies available for mirtazapine and Bewilderment
| Article | Year |
|---|---|
Hyponatraemia: the importance of obtaining a detailed history and corroborating point-of-care analysis with laboratory testing.
Topics: Aged; Confusion; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Medical History Taking; Mir | 2019 |
Safety in overdose of mirtazapine: a case report.
Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety; Confusion; Depressive Disorder; Dothiepin; Drug Ov | 1997 |